Provided by Tiger Trade Technology Pte. Ltd.

AKESO

89.900
-5.450-5.72%
Volume:14.10M
Turnover:1.28B
Market Cap:82.80B
PE:-62.51
High:93.700
Open:93.600
Low:89.600
Close:95.350
52wk High:159.800
52wk Low:80.200
Shares:921.00M
HK Float Shares:921.00M
Volume Ratio:0.98
T/O Rate:1.53%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.438
ROE:-13.59%
ROA:-4.57%
PB:8.36
PE(LYR):-62.51
PS:20.57

Loading ...

AKESO Schedules 29 June 2026 AGM; Shareholders to Vote on FY2025 Results, Board Line-up and 20% Issuance Mandate

Bulletin Express
·
Jun 05

Movement Alert|Akeso Rises 3.07% in Regular Trading, Technical Rebound After Four-Day Selloff as Multiple Brokerages Maintain Buy Ratings

Market Focus
·
Jun 05

China International Capital Corporation Highlights Prominent Role of Domestic Innovative Drugs at 2026 ASCO Conference

Stock News
·
Jun 04

Akeso Monthly Return Shows Stable Share Capital and Slight Dip in Outstanding Options

Bulletin Express
·
Jun 04

Guosen Securities Reaffirms "Outperform Market" Rating for AKESO Following Historic Ivonescimab Breakthrough

Stock News
·
Jun 04

Stock Track | Akeso Plummets 5.26% in Intraday Trading on Post-ASCO Profit-Taking and Sector Concerns

Stock Track
·
Jun 04

Movement Alert|Akeso Falls 3.16% in Regular Trading, Post-ASCO Profit-Taking Extends Selloff Below HKD 100

Market Focus
·
Jun 04

Bank of Communications International Retains 'Buy' Rating for AKESO with HK$175 Target Price

Stock News
·
Jun 03

Stock Track | Akeso Plummets 5.07% Intraday on Profit-Taking After ASCO Data, US Investment Concerns

Stock Track
·
Jun 03

Movement Alert|Akeso Inc Falls 3.1% in Regular Trading, Biotech Sector Extends Post-ASCO Pullback as Profit-Taking Continues

Market Focus
·
Jun 03

CICC Reiterates Outperform Rating on AKESO with HK$184 Target Price

Stock News
·
Jun 02

Stock Track | AKESO Plummets 7.94% Intraday as Profit-Taking Follows ASCO Rally Amid Large Block Sale

Stock Track
·
Jun 02

Movement Alert|Akeso Inc Falls 4.49% in Regular Trading, Large Block Sale Triggers Profit-Taking After ASCO Rally

Market Focus
·
Jun 02

An experimental lung-cancer drug could replace Keytruda one day. But investors aren't wowed.

Dow Jones
·
Jun 01

Major Volatility Hits Hong Kong Connect Innovative Drug Stocks: What Triggered the Sharp Turnaround?

Deep News
·
Jun 01

Summit drops as concerns over older patients cloud cancer trial data

Reuters
·
Jun 01

Mainland Investors Inject HK$4.66 Billion into Hong Kong Market; AKESO Leads with HK$2.7 Billion Inflow Following Positive OS Data

Stock News
·
Jun 01

CMSC Retains Strong Buy Rating on AKESO, Highlights Global Lung Cancer Market Potential

Stock News
·
Jun 01

AKESO's Landmark Clinical Data Ignites Stock Surge, Bolstering Hong Kong Connect Innovative Drug Sector

Deep News
·
Jun 01

Stock Track | AKESO Soars 9.74% Intraday on Positive Phase III Lung Cancer Trial Data at ASCO

Stock Track
·
Jun 01